About ADVANCE

The goal of the ADVANCE project is to help health professionals, regulatory agencies, public health institutions, vaccine manufacturers and the general public make more informed decisions on benefits and risks of marketed vaccines.

News

26/08/2017

ICPE 2017, Montreal, Canada

ADVANCE will be represented at the 33rd International Conference on...

31/05/2017

The WP4 White Paper has been submitted to IMI

We are pleased to inform you that the Deliverable D4.9 WP4 White Paper: methods...

17/05/2017

ADVANCE General Assembly and SAB Meeting

The ADVANCE 8th General Assembly and SAB Meeting will take place on May 17th...

Calendar

  • 26/08/2017ICPE 2017, Montreal, Canada
    ADVANCE will be represented at the 33rd International...

Links